HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kao, C. Articles by Jameson, S. C. Search for Related Content PubMed PubMed Citation Articles by Kao, C. Articles by Jameson, S. C.

The Sialyltransferase ST3Gal-I Is Not Required for Regulation of CD8-Class I MHC Binding during T Cell Development¹

University of Minnesota, Center for Immunology, Department of Laboratory Medicine and Pathology, Minneapolis, MN 55455

The CD8 coreceptor plays a crucial role in thymocyte and T cell sensitivity by binding to class I MHC and recruiting downstream signaling molecules to the TCR. Previous studies reported considerable changes in TCR-independent CD8/class I MHC binding (i.e., CD8 noncognate interactions) during T cell development, changes that correlated with altered glycosylation of surface molecules. In particular, expression of the sialyltransferase ST3Gal-I has been proposed as a critical factor regulating the attenuation of CD8 avidity during the double-positive to CD8 single-positive progression. This hypothesis is strengthened by the fact that ST3Gal-I^–/– animals show a profound disregulation of CD8 T cell homeostasis. In contrast to this model, however, we report in this study that ST3Gal-I deficiency had no detectable impact on CD8 noncognate binding to multimeric peptide/MHC class I ligands at any stage of thymocyte development. We also found that the susceptibility to CD8-induced cell death is not markedly influenced by ST3Gal-I deficiency. Thus, the profound effects of ST3Gal-I on CD8 T cell survival evidently do not involve a role for this enzyme in controlling CD8-class I binding.

This article has been cited by other articles:

				J. C. Varghese and K. P. Kane TCR Complex-Activated CD8 Adhesion Function by Human T Cells J. Immunol., November 1, 2008; 181(9): 6002 - 6009. [Abstract] [Full Text] [PDF]

				D. Gil, A. G. Schrum, M. A. Daniels, and E. Palmer A Role for CD8 in the Developmental Tuning of Antigen Recognition and CD3 Conformational Change J. Immunol., March 15, 2008; 180(6): 3900 - 3909. [Abstract] [Full Text] [PDF]

				D. Naeher, M. A. Daniels, B. Hausmann, P. Guillaume, I. Luescher, and E. Palmer A constant affinity threshold for T cell tolerance J. Exp. Med., October 29, 2007; 204(11): 2553 - 2559. [Abstract] [Full Text] [PDF]

				S. J. Van Dyken, R. S. Green, and J. D. Marth Structural and Mechanistic Features of Protein O Glycosylation Linked to CD8+ T-Cell Apoptosis Mol. Cell. Biol., February 1, 2007; 27(3): 1096 - 1111. [Abstract] [Full Text] [PDF]